Acceptability and feasibility of the use of 400 μg of sublingual misoprostol after mifepristone for medical abortion up to 63 days since the last menstrual period: evidence from Uzbekistan. [electronic resource]
Producer: 20130701Description: 104-11 p. digitalISSN:- 1473-0782
- Abortifacient Agents, Nonsteroidal -- administration & dosage
- Abortifacient Agents, Steroidal -- administration & dosage
- Abortion, Induced -- methods
- Administration, Intravaginal
- Administration, Sublingual
- Adult
- Drug Therapy, Combination
- Feasibility Studies
- Female
- Humans
- Mifepristone -- administration & dosage
- Misoprostol -- administration & dosage
- Patient Acceptance of Health Care -- psychology
- Pregnancy
- Pregnant People
- Prospective Studies
- Self Administration -- methods
- Uzbekistan
- Young Adult
No physical items for this record
Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.